TRT and HRT are two of the most under-marketed cash-pay services in healthcare. The total addressable market for low-testosterone treatment in the United States is estimated at over 15 million men, and only a small fraction are currently treated. Clinics that build a modern patient acquisition system for hormone optimization right now are entering a market with strong demand and surprisingly weak competition.
This playbook covers the funnel mechanics, ad-policy realities, and CPL benchmarks specific to TRT and HRT, not generic “healthcare marketing” advice retrofitted from another vertical. The differences matter, and clinics that treat HRT like a weight-loss campaign leave most of the performance on the table.
Why HRT and TRT Convert at Lower CPL Than Weight Loss
TRT campaigns on Meta consistently deliver cost per inquiry 30% lower than GLP-1 weight loss in the same market. The reason is audience intent. Weight-loss prospects are often compared shoppers. They have seen a dozen ads, evaluated multiple options, and are often emotionally fatigued. Men experiencing low testosterone symptoms have usually ignored the issue for years until they hit a moment of recognition, and the first ad that names what they are feeling lands hard.
Practical CPL benchmarks for TRT clinics on Meta in 2026: $15–$20 in mid-size markets, $20–$30 in major metros. Cost per booked consultation, with a deposit-gated funnel, runs $40–$80. At a $2,000/month Meta budget, that translates to roughly 75–110 booked consultations over 90 days, enough volume to make the unit economics work for clinics charging $200–$400/month for treatment.
Symptom-Led vs Outcome-Led Ad Copy
The single biggest creative decision in TRT marketing is whether to prospect with symptoms or outcomes. Symptom-led copy wins almost every time on Meta. Headlines like “Tired by 2pm every day?”, “Energy and focus dropped after 40?”, or “Lost the gym motivation you used to have?” speak to the felt experience of low testosterone without naming the diagnosis.
Outcome-led copy (“Increase testosterone naturally,” “Boost T levels,” or anything referencing TRT directly) consistently triggers Meta ad review and often gets rejected outright. Even when ads pass review, outcome-led copy underperforms because it speaks to people who already know they have low T. Symptom-led copy reaches the much larger audience who feel something is off but have not self-diagnosed.
“Men do not wake up wanting testosterone. They wake up tired, foggy, and flat. Lead the ad with the feeling, not the diagnosis, and you reach ten times the audience Google ever could,” says Simon Molay, founder of ScaleClinics.
What Meta Will and Won’t Allow in HRT Ads
Meta’s health advertising policy treats hormone replacement therapy as a regulated category. Ads cannot reference specific brand names of testosterone products, cannot promise specific outcomes (“feel like you did at 25”), and cannot use before/after imagery in the way fitness or weight-loss ads do. Body-comparison content is almost always rejected.
What works is testimonial-style UGC with men describing how they feel after treatment (without specific medical claims), educational content explaining the science of hormone decline, and lifestyle imagery of active men 35–65. The ad copy should funnel viewers to a quiz that handles the medical specifics post-click, where the platform’s ad policy no longer applies.
The TRT Funnel Architecture
The funnel that wins for TRT looks structurally similar to GLP-1 but differs in a few key details. The flow we run for HRT/TRT clinics:
1. Symptom-led Meta ad → 2. Custom quiz funnel(qualifying on age, symptoms, energy, sleep, libido, and current testosterone testing history) → 3. Refundable deposit gate → 4. Booking page → 5. AI follow-up if no booking within 15 minutes(twice a day for 7 days) → 6. SMS + email nurture for 90 days.
The quiz step is more important in TRT than in weight loss. Hormone treatment requires bloodwork and a real medical evaluation, so the funnel has to filter out men who are not actually candidates: men under 30 with no symptoms, men already on TRT looking to switch providers, men with disqualifying medical conditions. A well-built quiz filters these out before the calendar fills with no-fit consults.
Show-Rate Optimization for TRT
TRT consultations have a structurally higher show rate than weight-loss consultations when deposit-gating is used. Industry no-show rates for free TRT consultations run 25–40%; deposit-gated TRT funnels reduce that to 8–12%. The deposit works especially well in TRT because the typical patient is older, more financially stable, and more likely to value the appointment they paid for.
Recommended deposit amounts for TRT specifically: $50–$100, refundable and applied to the first treatment cycle. Below $50 the filter is too soft for TRT; above $100, booking volume drops faster than show rate improves. Pair with appointment reminders at 24 hours and 1 hour before the consultation to lock in the show.
Patient LTV and Why Acquisition Math Works
TRT patients have unusually strong lifetime value compared to other cash-pay verticals. Average treatment duration runs 18–36 months at $200–$400/month, which puts LTV in the $4,000–$10,000 range. Even at the high end of acquisition cost ($150–$200 per booked patient on cold Meta traffic), payback period is one or two months and lifetime ROI clears 25x.
This is why specialized HRT/TRT clinics can spend more aggressively on patient acquisition than general med-spas, and why the clinics that build a real funnel before competition catches up will dominate their markets for the next several years.
Common Mistakes Clinics Make in TRT Marketing
The most common mistakes we see in TRT clinic marketing: leading ad copy with the word “testosterone” (instant policy review trigger), running generic men’s-health funnels that do not qualify for actual treatment eligibility, skipping the deposit gate to maximize raw booking volume (which collapses show rate), and outsourcing creative to teams unfamiliar with healthcare ad policy.
The fix in every case is to build the funnel for the specific mechanics of TRT, not for generic healthcare marketing. The agencies and clinics that treat hormone optimization as its own discipline win the unit economics; the ones who copy GLP-1 playbooks waste 30–50% of their ad budget.